2026-07-21T14:00:38Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/177942024-09-21T18:03:29Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16938col_20.500.12105_16927col_20.500.12105_16958col_20.500.12105_16968col_20.500.12105_16982
Repisalud
author
González-Flores, E
author
Serrano, R
author
Sevilla, I
author
Viúdez, A
author
Barriuso, J
author
Benavent, M
author
Capdevila, J
author
Jimenez-Fonseca, P
author
López, C
author
Garcia-Carbonero, R
2024-02-09T16:00:16Z
2024-02-09T16:00:16Z
2018-12-07
10.1007/s12094-018-1980-7
1699-3055
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
http://hdl.handle.net/10668/13305
30535553
http://hdl.handle.net/20.500.12105/17794
NENs are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise across all sites, stages and grades. Although improved diagnostic techniques have led to earlier detection and stage migration, the improved prognosis documented over time for advanced gastrointestinal and pancreatic neuroendocrine tumors also reflect improvements in therapy. The aim of this guideline is to update practical recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification and therapeutic options are briefly discussed, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, and treatment algorithms are provided.
eng
Diagnosis
Gastroenteropancreatic
Guidelines
Lung
Neuroendocrine neoplasms
Neuroendocrine tumors
Therapy
SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
research article